Clinical Trials Directory

Trials / Completed

CompletedNCT04782050

Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation

Diagnostic échographique Non-invasif Des Maladies Chroniques du Foie en Consultation d'hépatologie

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
E-Scopics · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Early screening and monitoring of chronic liver diseases in hepatology practice has become crucial. To achieve this goal, hepatology clinics need simple and available tools at the point-of-care to perform disease severity assessment. The objective of this study is to assess the performance of a new non-invasive ultrasound-based system for the assessment of liver fibrosis and steatosis severity, via ultrasound biomarkers such as tissue stiffness (correlated to fibrosis severity) and ultrasound tissue attenuation (correlated to steatosis extent).

Detailed description

The study will enroll adult patients with known chronic liver disease, and referred to a hepatology outpatient visit for liver fibrosis assessment. Performances will be assessed from correlation coefficients between biomarkers estimated by the medical device subject of the research and reference measurements obtained non-invasively from other commercially available equipment. Repeatability and reproducibility of biomarkers estimations by the medical device subject of the research will be assessed from intraclass correlation coefficients.

Conditions

Interventions

TypeNameDescription
DEVICEUltrasound liver assessmentThe intervention consists in an ultrasound exam performed with the ultrasound medical device subject of the research.

Timeline

Start date
2021-09-15
Primary completion
2022-08-29
Completion
2022-08-29
First posted
2021-03-04
Last updated
2023-04-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04782050. Inclusion in this directory is not an endorsement.